45540 Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices 
DATES : The Agency will consider public 
comments on the settlement until 
August 31, 2015. The Agency will consider all comments received and may modify or withdraw its consent to the settlement if comments received disclose facts or considerations which indicate that the amended settlement is inappropriate, improper, or inadequate. 
ADDRESSES : Copies of the settlement are 
available from the Agency by contacting Ms. Paula V. Painter, Environmental Protection Specialist using the contact information provided in this notice. Comments may also be submitted by referencing the Site’s name through one of the following methods: 
•Internet: www.epa.gov/region4/
superfund/programs/enforcement/enforcement.html. 
•U.S. Mail: U.S. Environmental 
Protection Agency, Superfund Division, Attn: Paula V. Painter, 61 Forsyth Street SW., Atlanta, Georgia 30303. 
•Email: Painter.Paula@epa.gov. 
FOR FURTHER INFORMATION CONTACT : 
Paula V. Painter at (404) 562–8887. 
Dated: June 9, 2015. 
Anita L. Davis, 
Chief, Enforcement and Community 
Engagement Branch, Superfund Division. 
[FR Doc. 2015–18727 Filed 7–29–15; 8:45 am] 
BILLING CODE 6560–50–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
Food and Drug Administration 
[Docket No. FDA–2008–N–0397] 
Agency Information Collection 
Activities; Announcement of Office of Management and Budget Approval; State Enforcement Notifications 
AGENCY : Food and Drug Administration, 
HHS. 
ACTION : Notice. 
SUMMARY : The Food and Drug 
Administration (FDA) is announcing that a collection of information entitled, ‘‘State Enforcement Notifications’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. 
FOR FURTHER INFORMATION CONTACT : FDA 
PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@fda.hhs.gov. 
SUPPLEMENTARY INFORMATION : On June 8, 
2015, the Agency submitted a proposed collection of information entitled, ‘‘State Enforcement Notifications’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0275. The approval expires on July 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain. 
Dated: July 24, 2015. 
Leslie Kux, 
Associate Commissioner for Policy. 
[FR Doc. 2015–18649 Filed 7–29–15; 8:45 am] 
BILLING CODE 4164–01–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
Food and Drug Administration 
[Docket No. FDA–2015–N–1305] 
Multicriteria-Based Ranking Model for 
Risk Management of Animal Drug Residues in Milk and Milk Products; Extension of Comment Period 
AGENCY : Food and Drug Administration, 
HHS. 
ACTION : Notice; extension of comment 
period. 
SUMMARY : The Food and Drug 
Administration (FDA or we) is extending the comment period for the risk assessment entitled ‘‘Multicriteria- Based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products.’’ A notice of the availability of the risk assessment and our request for comments appeared in the Federal Register of April 30, 2015. We initially established July 29, 2015, as the deadline for the submission of requested comments that can help improve the ranking model approach, including the specific criteria, scoring, and weighting scheme; the scientific data and assumptions used to inform scoring used in the model; the selection of animal drugs evaluated; and the clarity and the transparency of the risk assessment. We are taking this action in response to a request for an extension to allow interested persons additional time to submit comments. 
DATES : FDA is extending the comment 
period on the risk assessment whose availability we announced in a notice published on April 30, 2015 (80 FR 24260). Submit either electronic or written comments on the risk assessment by October 27, 2015. ADDRESSES : You may submit comments 
by any of the following methods: 
Electronic Submissions 
Submit electronic comments in the 
following way: 
•Federal eRulemaking Portal: http:// 
www.regulations.gov. Follow the 
instructions for submitting comments. Written Submissions 
Submit written submissions in the 
following ways: 
•Mail/Hand delivery/Courier (for 
paper submissions): Division of Dockets 
Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 
Instructions: All submissions received 
must include the Docket No. FDA– 2015–N–1305. All comments received may be posted without change to http:// 
www.regulations.gov, including any 
personal information provided. For additional information on submitting comments, see the ‘‘Comments’’ heading of the 
SUPPLEMENTARY INFORMATION  
section of this document. 
Docket: For access to the docket to 
read background documents or comments received, go to http://www.regulations.gov and insert the 
docket number(s), found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 
FOR FURTHER INFORMATION CONTACT : Jane 
Van Doren, Center for Food Safety and Applied Nutrition (HFS–005), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240– 402–2927. 
SUPPLEMENTARY INFORMATION : 
I. Background 
In the Federal Register of April 30, 
2015, FDA published a notice announcing the availability of a risk assessment entitled ‘‘Multicriteria-Based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products,’’ with a 90-day comment period to request comments on the risk assessment. 
We received a request for a 90-day 
extension of the comment period for the risk assessment. The request conveyed concern that the current 90-day comment period does not allow sufficient time to develop meaningful or thoughtful comments to the risk assessment. 
FDA has considered the request and 
is extending the comment period for the risk assessment for 90 days, until October 27, 2015. We believe that a 90- 
VerDate Sep<11>2014 14:54 Jul 29, 2015 Jkt 235001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\30JYN1.SGM 30JYN1Lhorne on DSK7TPTVN1PROD with NOTICES45541 Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices 
day extension allows adequate time for 
interested persons to submit comments. 
II. Request for Comments 
Interested persons may submit either 
electronic comments regarding this 
document to http://www.regulations.gov or written comments to the Division of Dockets Management (see 
ADDRESSES ). It 
is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov. 
III. Electronic Access 
Persons with access to the Internet 
may obtain the risk assessment at http:// 
www.fda.gov/Food/
FoodScienceResearch/
RiskSafetyAssessment/ucm443549.htm. 
Dated: July 24, 2015. 
Leslie Kux, 
Associate Commissioner for Policy. 
[FR Doc. 2015–18668 Filed 7–29–15; 8:45 am] 
BILLING CODE 4164–01–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
Food and Drug Administration 
[Docket No. FDA–2010–N–0155] 
Agency Information Collection 
Activities; Announcement of Office of Management and Budget Approval; Veterinary Feed Directive 
AGENCY : Food and Drug Administration, 
HHS. 
ACTION : Notice. 
SUMMARY : The Food and Drug 
Administration (FDA) is announcing that a collection of information entitled ‘‘Veterinary Feed Directive’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. 
FOR FURTHER INFORMATION CONTACT : FDA 
PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@fda.hhs.gov. 
SUPPLEMENTARY INFORMATION : On May 
19, 2015, the Agency submitted a proposed collection of information entitled ‘‘Veterinary Feed Directive’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0363. The approval expires on July 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain . 
Dated: July 24, 2015. 
Leslie Kux, 
Associate Commissioner for Policy. 
[FR Doc. 2015–18650 Filed 7–29–15; 8:45 am] 
BILLING CODE 4164–01–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
National Institutes of Health Proposed Collection; 60 Day Comment 
Request Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD) 
Summary: In compliance with the 
requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institutes of Health (NIH), Office of the Director (OD), will publish periodic summaries of proposed projects to the Office of Management and Budget (OMB) for review and approval. 
Written comments and/or suggestions 
from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. 
To Submit Comments and for Further 
Information: To obtain a copy of the 
data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Mikia P. Currie, Program Analyst, Office of Policy for Extramural Research Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll-free number 301–435–0941 or Email your request, including your address to curriem@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. 
Comments Due Date: Comments 
regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. 
Proposed Collection: Conference, 
Meeting, Workshop, and Poster Session Registration Generic Clearance (OD), 0925–New, National Institutes of Health (NIH), Office of the Director (OD). 
Need and Use of Information 
Collection: The information collections 
encompassed by this generic clearance will allow the NIH to select the most appropriate participants for non-grantee activities sponsored, organized, and run by the NIH staff, according to the type and purpose of the activity. For example, the NIH may develop an application process or information collection to select a limited number of researchers to participate in a poster session, identify speakers and panelists with desired expertise on a specific topic to be covered at a meeting, or determine which researchers would most likely benefit from a training course or other opportunity. For the NIH to plan and conduct activities that are timely for participants and their fields of research, it is often necessary for such information to be collected with a relatively short turnaround time. In general, submitted abstracts or other application materials will be reviewed by an internal NIH committee responsible for planning the activities. This committee will be responsible for selecting and notifying participants. 
The information collected for these 
activities generally includes title, author(s), institution/organization, poster size, character limitations along with other requirements. This information is necessary to identify attendees as eligible for poster presentations, to present their research, speak on panels, and discuss innovative approaches to science and technology to their peers. The registration form collects information from interested parties necessary to register them for a workshop. 
OMB approval is requested for 3 
years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 8,500. 
VerDate Sep<11>2014 14:54 Jul 29, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\30JYN1.SGM 30JYN1Lhorne on DSK7TPTVN1PROD with NOTICES